Article: LecTec adopts strategic restructuring plan; action enables LecTec to move forward toward achieving promising future opportunities.

MINNETONKA, Minn.--(BW HealthWire)--March 31, 1997--LecTec Corporation (NASDAQ/NMS:LECT) today announced that its Board of Directors has adopted a restructuring plan designed to result in the elimination of the company's Pharmadyne Corporation subsidiary.

As a result of the restructuring plan, the company will record a non-recurring charge of approximately $1,500,000 or 39 cents per share, in the third quarter of fiscal 1997 which ends March 31. The restructuring charge includes approximately $700,000 for the acquisition of the minority interests in Pharmadyne in exchange for newly issued shares of LecTec common stock, and approximately $500,000 representing ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!